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Abstract
Photoreceptor peripherin/rds promotes membrane fusion, through a putative fusion domain located within the C-terminus
(Boesze-Battaglia et al., Biochemistry 37 (1998) 9477^9487). A peptide analogue to this region, PP-5, competitively inhibits
peripherin/rds mediated fusion in a cell free assay system. To characterize how this region is involved in the fusion process we
investigated two of the individual steps in membrane fusion, membrane adhesion and membrane destabilization inferred
from depolarization studies. Membrane depolarization was measured as the collapse of a valinomycin induced K diffusion
potential in model membranes, using a potential sensitive fluorescent probe, diS-C2-5. PP-5 induced membrane
depolarization in a concentration dependent manner. PP-5 has been shown by Fourier transform infrared spectroscopy to
be an amphiphilic K-helix. Therefore, the requirement for an amphiphilic K-helix to promote depolarization was tested using
two mutant peptides designed to disrupt either the amphiphilic nature of PP-5 (PP-5AB) or the K-helical structure (PP-5HB).
PP-5AB inhibited PP-5 induced depolarization when added in an equimolar ratio to PP-5. Neither mutant peptide alone or in
combination with PP-5 had any effect on calcium dependent vesicle aggregation. Using non-denaturing gel electrophoresis
and size exclusion chromatography techniques PP-5 was shown to form a tetrameric complex. Equimolar mixtures of PP-5
and PP-5AB formed a heterotetramer which was unable to promote membrane depolarization. The hypothesis that PP-5
tetramers promote membrane depolarization is consistent with the calculated Hill coefficient of 3.725, determined from a Hill
analysis of the depolarization data. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Membrane fusion processes are essential for nor-
mal development and physiological function in all
cell types [1,2]. A commonality among most fusion
processes is the mediation and regulation of these
processes by unique fusion proteins (for review see
[3]) which share common motifs (i.e. fusion peptide
regions). A characteristic structural feature of viral
fusion proteins [3] and of mammalian fusion pro-
teins, such as fertilin [4^6] and meltrin [7], is the
presence of short fusion peptides generally 16^26
amino acids in length. Such fusion peptides are often
part of a membrane anchored domain and may be
internal to the polypeptide chain [8]. Molecular mod-
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eling and biophysical studies show that some fusion
peptides form amphiphilic K-helical structures [9^12],
while others form L-structures [13]. Most of these
peptides are oriented obliquely within the opposing
bilayer [14] and destabilize the target membrane
[8,10,14^17] and/or host membranes [18^22]. In a
number of fusion systems these fusion peptide re-
gions mediate the individual steps in fusion as multi-
meric complexes. The precise oligomeric state of a
number of these peptides has been identi¢ed; hemag-
glutinin (HA) induced fusion, for example, requires
the cooperation of at least three HA trimers [23].
Fusion processes also play an important role in
maintaining the normal structure of retinal rod cells.
In the outer segment region of the cell, the coordi-
nated processes of disk morphogenesis (at base) and
disk shedding (at tip) de¢ne a program of outer seg-
ment renewal and disposal [24]. These processes
maintain a stack of closed £attened membranous
disks organized in a discontinuous lateral array. A
step during both new disk closure and disk mem-
brane packet formation prior to shedding requires
the fusion of opposing membranes. Fusion during
disk packet formation is documented in microscopic
studies showing rod outer segment (ROS) vesicula-
tion and tubulation in the region of old disks and
packet formation [25^28]. An analysis of dye pene-
tration into distinct regions of the ROS and the ob-
servation that large molecules do not enter the nar-
row bands of dye stained region of the ROS suggest
a fusion of the plasma membrane with the disk mem-
branes [29^31]. Fusion between these two membranes
has since been modeled in cell free assay systems [32^
35].
We have recently identi¢ed a candidate fusion pro-
tein, called peripherin/rds, in photoreceptor rod cells.
Peripherin/rds is located within the disk rim [36], the
surface that contacts and fuses with plasma mem-
brane in disk packet formation. It is a 39 kDa inte-
gral membrane glycoprotein consisting of four trans-
membrane domains and two intradiskal loops [37^
39]. A portion of the C-terminus (residues 294^315)
is highly conserved between and within species (i.e.
Xenopus, human, mouse, rat, bovine and chicken
[40]) and at least one C-terminal serine residue is
phosphorylated [33]. Within the ROS disk rim, pe-
ripherin/rds forms disul¢de linked homodimers
which complex non-covalently with a non-glycosylat-
ed homologue, rom-1, to form a heterotetrameric
complex [41^45]. Using a cell free fusion assay sys-
tem as a model of the fusion between disk rims and
plasma membrane, we have shown that puri¢ed pe-
ripherin/rds promotes membrane fusion [33,34]. Fu-
sion is mediated through at least one region of the C-
terminal domain from residues 311 to 325, hypothe-
sized to serve as a fusion peptide. We have previously
shown that a peptide analogue to this region, called
PP-5, inhibits fusion between ROS plasma mem-
brane and peripherin/rds recombinants and promotes
membrane adhesion and model membrane fusion
[34]. This peptide is an amphiphilic K-helix based
on Fourier transform infrared spectroscopy (FTIR
[34]), a structure consistent with that of other mem-
brane fusion peptides [2^4].
Since biological membrane fusion is a complex
series of biochemical events, attempts to understand
the steps in the fusion process rely on the use of
simpli¢ed model systems. Synthetic peptides that
are analogous to, or closely resemble the fusion pep-
tide regions of fusion proteins have been used exten-
sively in model membrane studies to understand the
molecular mechanism by which these regions pro-
mote fusion. Peptide analogues of HIV-1 gp41
[46,47], Sendai virus F1 [48], baculovirus GP64 [49],
measles virus F1 [50], S-protein of hepatitis [51] and
sperm fertilin [52] fusion peptide regions have al-
lowed elucidation of the mechanism(s) by which
these fusion proteins promote infection and fertiliza-
tion.
While PP-5 has been shown to promote membrane
adhesion and model membrane fusion, its role in
membrane destabilization, another prerequisite step
in fusion, has until now not been evaluated. In the
studies described herein, PP-5 is shown to promote
membrane destabilization, in the form of di¡usion
potential collapse, and aggregation in a dose depen-
dent fashion. Analogous to other membrane fusion
peptides, the requirement for an amphiphilic K-heli-
cal structure to mediate the steps in fusion was also
demonstrated with two mutant peptides designed to
alter the biophysical properties of PP-5. Wild type
and mutant peptide to self- and co-assembly was
evaluated and the ability of PP-5 to promote mem-
brane depolarization is discussed in the context of
oligomer formation. These data provide additional
and more compelling support for the identi¢cation
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of this region as a fusion peptide within peripherin/
rds and adds to the growing list of fusion peptides
with common structural and functional properties
[3].
2. Experimental procedures
2.1. Materials
Phosphatidylserine (PS, bovine brain), phosphati-
dylcholine (PC, egg), phosphatidylethanolamine (PE)
and cholesterol used to synthesize small unilamellar
vesicles (SUVs) and large unilamellar vesicles (LUVs)
were purchased from Avanti Polar Lipids (Atlanta,
GA). All other chemicals were purchased from Sig-
ma (Saint Louis, MO). PP-5 corresponding to resi-
dues 311^325 in the C-terminal region of bovine pe-
ripherin/rds and mutant peptides designated PP-5HB
and PP-5AB where purchased from Quality Control
Biochemicals (QCB). PP-3 corresponding to residues
331^345 in the C-terminal region of bovine peripher-
in/rds was synthesized by QCB.
2.2. Membrane permeability studies
Membrane bilayer destabilization was inferred
from membrane depolarization studies and measured
£uorimetrically with the cation sensitive dye, diS-C2-
5, as a collapse in a valinomycin induced di¡usion
potential in model membranes [53]. SUVs composed
of phosphatidylcholine:phosphatidylserine:cholester-
ol in a 4:4:1 molar ratio were prepared by probe
sonication in the presence of K containing bu¡er
(50 mM K2SO4, 10 mM HEPES-SO4, pH 6.8). An
aliquot of the SUVs (phospholipid concentra-
tion = 36 nmoles) was added to 10 ml of isotonic
bu¡er (50 mM Na2SO4, 10 mM HEPES-SO4, pH
6.8) containing 10 Wl of the £uorescent probe diS-
C2-5 (stock = 1 mM) and incubated at 37‡C until a
stable baseline £uorescence was established. The ad-
dition of valinomycin (¢nal concentration = 1037 M),
selectively permeabilized the vesicles to K, creating
a negative di¡usion potential inside the vesicles re-
sulting in the quenching of the dye’s £uorescence.
Peptides from a 1 mg/ml stock in either dH2O or
K-free bu¡er were added in 25, 75, or 100 Wl ali-
quots. Fluorescence was recorded at Vex = 620 nm
and Vem = 670 nm for 90 min after the addition of
the various peptides. An increase in £uorescence in-
tensity upon the addition of peptides was indicative
of a dissipation of the di¡usion potential due to pep-
tide induced destabilization. To quantitate the total
£uorescence recovered, £uorescence was monitored
before the addition of valinomycin, following the
addition of valinomycin and after the addition of
the desired peptide. The percent £uorescence recov-
ery was calculated as described previously [53], using
the equation below:
F t  I t3Io=I f3IoU100
It is the £uorescence after the addition of the peptide,
at time t, Io is £uorescence after the addition of va-
linomycin, If = £uorescence intensity prior to the ad-
dition of valinomycin. Mellitin (¢nal concentra-
tion = 9.0 Wg/ml) was added to con¢rm that the
increase in £uorescence observed was due to a col-
lapse in the di¡usion potential. In all of the perme-
ability studies mellitin was able to dissipate the vali-
nomycin induced di¡usion potential after the
addition of those peptides which had no e¡ect.
2.3. Vesicle aggregation experiments
Change in vesicle size was monitored using UV/
VIS spectroscopy essentially as described [34,53].
The SUVs were composed of PC:PS:CHOL (4:4:1)
and prepared in the presence of 16 WM Ca2 [34].
Aliquots of the various peptides were added individ-
ually and in combination to SUVs as described in the
¢gure legends. Vesicle aggregation was monitored as
a change in vesicle size, detected as a change in ab-
sorbance at 380 nm, recorded every 0.1 min for
10 min. Reversible aggregation was distinguished
from fusion with the addition of 1 M EDTA to a
¢nal concentration of 33 mM and the absorbance
monitored for an additional 3 min. All aggregation
studies were performed at 37‡C.
2.4. Size exclusion chromatography
The oligomeric state of the peptides was deter-
mined using size exclusion HPLC, with a HR10/30
Superdex column (internal diameter 10 mm, 30 cm
column length, bed volume, 24 ml; Pharmacia, Bio-
tech), eluted with an isocratic gradient of 0.25 M
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NaCl in 0.02 M Na2HPO4 pH 7.40 at a £ow rate of
0.25 ml/min or 0.50 ml/min as indicated. The elution
was monitored at 214 nm and the individual peptide
species isolated. Samples were routinely loaded onto
the column in distilled water from a 1 mg/ml stock
solution. The injection volumes varied from 25 to
100 Wl (corresponding to 5^30 nmoles) as described
in the ¢gure legends and tables. The molecular
weights of the oligomeric complexes was determined
by comparison to proteins of known molecular mass
(cytochrome c 12 500 Da, aprotinin 6500 Da, gastrin
2126 Da, substance P 1348 Da, (Gly)6 360 Da, (Gly)3
189 Da and glycine 75 Da). The various peak assign-
ments were based on individual runs of the various
peptides compared to the elution volume of the
standards.
2.5. Peptide binding studies
The extent of peptide association with small uni-
lamellar PS:PC:CHOL (4:4:1) vesicles was mea-
sured using a rhodamine labeled PP-5 derivative, des-
ignated RhPP-5 (sequence shown in Table 1). SUVs
were added to RhPP-5 at 37‡C as described by others
in tryptophan binding experiments [54,55]. The rhod-
amine £uorescence intensity was measured as a func-
tion of increasing lipid to peptide ratio with a
Vex = 560 nm (slit width = 10) and Vem = 590 nm (slit
width = 20). No change in RhPP-5 £uorescence was
observed when bu¡er was added in amounts equal to
the volume of SUVs.
2.6. Denaturing and non-denaturing gel
electrophoresis
Peptides were separated on discontinuous denatur-
ing tricine gels containing 6 N urea and discontinu-
ous non-denaturing tricine gels containing 6 N gly-
cine [56]. The discontinuous gels consisted of a 5 cm
separating gel (16.5% tricine, 6% C w/6 N urea), 1 cm
spacer gel (10% tricine, 3% C) and 1 cm stacking gel
(4% tricine, 3% C), where ‘C’ refers to the bis-acryl-
amide content. Gels were stained with Coomassie
blue [57] or silver stained [58]. The molecular weights
of the peptides were determined using Rf measure-
ments from molecular weight markers. In some cases
peptides were also separated using 12.5% SDS-
PAGE as described [34,57], based on the system of
Laemmli [59].
2.7. Additional assays and analyses
Phosphate was determined as described [60] and
modi¢ed [61]. Total protein was determined using a
Bio-Rad microassay procedure (Sigma). The predica-
tion of the secondary structure and the hydropathy
index of the individual peptides was derived on a
Silicon graphics VGX workstation using a loop
search technique with SYBYL. The secondary struc-
ture was predicted according to the method of Rob-
son-Garnier [62] and the hydrophilicity plots calcu-
lated according to the algorithm of Hopp and
Woods [63]. Hill plots were constructed and the
Hill coe⁄cient calculated as described [64]. In depo-
larization studies Y was de¢ned as the percent £uo-
rescence recovery. In the aggregation studies Y was
de¢ned as the change in absorbance at 380 nm. The
slope of the plot of log[peptide concentration] versus
log Y/[Ytotal3Y] is equal to the Hill coe⁄cient and
was calculated using Sigma-plot linear regression
software. The data were ¢rst analyzed using Sigma
Stat to determine whether the best ¢t was a ¢rst or
Table 1
Amino acid sequence of peripherin/rds peptides and a rhodamine labeled analogue
Designation Sequence Molecular weight (g/mole)
PP-5 H2N-VPETWKAFLESVKKL-COOH 1 819.2
PP-5AB H2N-VPETWKAYLESEKKL-COOH 1 848.2
PP-5HB H2N-VPETWPAFLESVKKL-COOH 1 787.2
Rh-PP-5 Rho-HN-VPETWK*AFLESVK*K*L-COOH 2 251.0
PP-3 H2N-VEAEGEDAGQAPAAG-COOH 1 694.3
PP-2 H2N-RKRSDVMNNSDSHFV-COOH 1 859.0
* designates a trypsin cleavage site.
The amino acids indicated in bold are those residues altered in the mutant peptides.
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second order equation, which was then used for Hill
analysis.
3. Results
Photoreceptor peripherin/rds contains a candidate
fusion peptide region within the C-terminus [33,34],
corresponding to amino acids 311^325. A peptide
representing this fusion domain (PP-5), two mutant
peptides and several other peptides of overlapping
regions of the C-terminus were synthesized and
used in the following studies. The wild type (WT)
peptide was £uorescently labeled at its N-terminus
with rhodamine and used in self-assembly studies.
The sequences, molecular weights, and the designa-
tions given these peptides are shown in Table 1.
3.1. PP-5 depolarizes model membrane
To delineate how the fusion domain of peripherin/
rds promotes membrane fusion and to provide addi-
tional support for the role of PP-5 as a fusion pep-
tide region of peripherin/rds we investigated the abil-
ity of this peptide to perturb membrane structure.
Membrane destabilization was inferred as an increase
in £uorescence of the £uorophore, diS-C2-5, caused
by a dissipation of a valinomycin induced K di¡u-
sion potential [65]. The ability of synthetic peptide
analogues corresponding to the C-terminus of pe-
ripherin/rds, designated PP-3 to PP-7 corresponding
to a 40 amino acid long region of the C-terminus
(Table 1 and described previously [34]) to dissipate
the valinomycin induced K di¡usion potential, was
tested. An increase in diS-C2-5 £uorescence intensity
occurred only when PP-5 was added to the valino-
mycin treated LUVs (Fig. 1). In contrast, the £uo-
rescence intensity was unaltered with the addition of
any of the other peptide analogues studied (PP-3 to
PP-7, data not shown).
FTIR analysis of PP-5 showed that this peptide is
an amphiphilic K-helix in aqueous solution [34]. To
investigate the e¡ects of amphiphilicity and helical
structure on PP-5 dependent aggregation, two mu-
tant peptide analogues of PP-5, PP-5HB and PP-
5AB, were designed to alter either the amphiphilic
nature or the K-helical structure of PP-5. PP-5AB
di¡ers from PP-5 at two amino acids, the ¢rst,
F318Y and the second, V322E. These substitutions
are designed to disrupt the segregated distribution of
hydrophilic and hydrophobic residues within the
peptide and are designated an amphiphilic breaker.
These two amino acid substitutions result in a more
Fig. 2. Percent £uorescence recovery versus peptide to phospho-
lipid (mole:mole) ratio. The maximum £uorescence recovery of
diS-C2-5 at 37‡C is plotted as a function of PP-5 to phospho-
lipid molar ratios in samples containing PP-5 (b) alone, an
equimolar mixture of PP-5 and PP-5HB (a), and an equimolar
mixture of PP-5 and PP-5AB (S). The results are a summary
of two independent experiments with two di¡erent batches of
PP-5.
Fig. 1. PP-5 induced dissipation of valinomycin induced di¡u-
sion potential in phosphatidylcholine:phosphatidylserine:choles-
terol SUVs. The £uorescence intensity of diS-C2-5, at Vex = 620
nm and Vem = 670 nm was followed over time. The addition of
PP-5 (concentration = 20 Wg) to the vesicles containing valino-
mycin is shown by an arrow. The results shown are of a repre-
sentative experiment.
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hydrophilic structure with a net charge of zero and
an increase in the predicted hydropathy index. Model
studies suggest that the K-helical structure of this
peptide is unaltered (data not shown). The other mu-
tant peptide with a L316P substitution, called PP-
5HB, is predicted by molecular modeling to have a
disordered secondary structure (data not shown).
As seen in Fig. 2, increasing amounts of equimolar
mixtures of PP-5 and PP-5 AB (relative to phospho-
lipid) were unable to promote depolarization, sug-
gesting that PP-5 induced depolarization is inhibited
by PP-5AB. In contrast, when PP-5 and PP-5 HB
were added simultaneously, in equimolar amounts,
the di¡usion potential dissipated to the same extent
as that observed with PP-5 alone (data not shown).
3.2. Characterization of peptide oligomerization
A common characteristic of membrane fusion pep-
tides is the formation of oligomeric complexes which
act to promote the steps in fusion. The non-linear
relationship between % depolarization and molar ra-
tio of PP-5 suggests that PP-5 dependent depolariza-
tion is dependent on PP-5 oligomerization. To ad-
dress the relationship between PP-5 function
(depolarization) and its structure, the oligomeric
forms of the peptides were characterized using dis-
continuous gel electrophoresis (summarized in Table
2). The most prevalent form of PP-5 under denatur-
ing conditions is a complex with a molecular weight
of 3600 indicative of a dimer. The apparent absence
of PP-5 monomers is similar to other fusion peptides
which form stable complexes in the presence of SDS
[66] and denature only at extremely high tempera-
tures. We have previously shown using FTIR that
native peripherin/rds denatures at extremely high
temperatures [33].
Under non-denaturing electrophoresis conditions,
PP-5 migrated within an apparent molecular mass
range of 6800^7200 Da, indicative of a tetramer. In
the HPLC analysis, PP-5 eluted with an apparent
molecular mass of 7500^8400 Da indicative of a tet-
ramer with less than 10% corresponding to a dimer
(Fig. 3A, peak A and B respectively). Analysis of the
two mutant peptides, PP-5AB and PP-5HB, showed
PP-5HB to be dimeric (Fig. 3B, peak CP) and PP-
5AB to form a tetramer and a trimer (Fig. 3B, peak
AP and BP respectively). An equimolar mixture of PP-
5 and PP-5AB formed a tetramer and a dimer (data
not shown).
3.3. PP-5 self-assembly in the presence of SUVs
The data above demonstrating the presence of
multiple oligomeric forms of PP-5 suggest the self-
assembly of this peptide in solution. To gain addi-
tional support for PP-5 self-association, a rhodamine
labeled analogue of PP-5 was synthesized (Table 1).
Fig. 3. Elution pro¢le of PP-5 and mutant peptides. (A) The
elution pro¢le of PP-5 separated on a HR10/30 Superdex col-
umn eluted with an isocratic gradient of 0.25 M NaCl in 0.02
M Na2HPO4 pH 7.40 at a £ow rate of 0.25 ml/min was moni-
tored at 214 nm. (B) The elution pro¢le of an equimolar mix-
ture of PP-5HB with PP-5AB under the same experimental con-
ditions as in A. Peak assignments were based on individual
runs of the various peptides and elution volumes of the stan-
dards as described in Section 2.
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The £uorescence of RhPP-5 at Vem = 586 nm was
monitored in an aqueous environment and in the
presence of SUVs prepared exactly as described in
the depolarization studies (i.e. PC:PS:CHOL
4:4:1). The emission spectra of RhPP-5 in aqueous
solution re£ected the £uorescence of the rhodamine
moiety with a decrease in intensity as the concentra-
tion of RhPP-5 was increased (data not shown). Sim-
ilarly in the presence of lipid vesicles, when the
amount of vesicles present in the assay was doubled,
the £uorescence intensity at 586 nm decreased from
178 £uorescence units to 124 £uorescence units
Fig. 4. Fluorescence emission spectra of RhPP-5 in the presence of increasing amounts of SUVs. The £uorescence emission spectra of
20 nM RhPP-5 from 560 to 650 nm at a Vex = 560 nm is shown in bu¡er, (curve f) and in the presence of increasing amounts of
PC:PS:CHOL (4:4:1) SUVs at 37‡C (curves a^e). The phospholipid concentration in the assay during each scan is as follows: e, 25
nM; d, 130 nM; c, 0.25 WM; b, 0.52 WM; a, 0.77 WM.
Table 2
Oligomeric complexes formed by peripherin/rds peptides
Peptides Predicted oligomeric form
Denaturing conditions Non-denaturing conditions
Gels HPLC
PP-5 3 600 (dimer) 7 200(tetramer) 7 650(tetramer)
PP-5+PP-5HB 2 930 (dimer) 8 000(tetramer) 7 800(tetramer)
3 700(dimer)
PP-5+PP-5AB 4 660 (trimer, 98%) 7 200(tetramer) 7 850(tetramer)
3 030 (dimer, 2%) 3 580(dimer) 3 500(dimer)
PP-5HB+PP-5AB 4 720 (trimer, 93%) 7 500(tetramer) 7 500(tetramer)
3 190 (dimer, 6%) 15 000(octamer) 13 500(octamer)
The molecular weights of the various peptides were determined under denaturing and non-denaturing conditions as described in Sec-
tion 2. The predicted oligomeric forms of the peptides given in parentheses are based on the molecular weights of the peptides shown
in Table 1.
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(curve c and b respectively, Fig. 4). The simplest
interpretation for the decrease in £uorescence inten-
sity is a self-quenching of the £uorescence probe as
would occur during self-assembly [67].
The oligomeric forms of mixtures of RhPP-5 and
PP-5 were analyzed using HPLC size exclusion chro-
matography with the eluate monitored at 585 nm to
detect rhodamine labeled PP-5 and 214 nm to detect
peptide. The chromatograms detected the presence of
two molecular species with molecular masses of 8250
Da (peak A) and 3960 Da (peak B). Complexes of
nearly identical molecular masses were detected in
mixtures of RhPP-5 and PP-5AB at both wave-
lengths (Fig. 5, peaks A, B, AP, BP), suggesting the
formation of heterooligomers. Mixtures of RhPP-5
and PP-HB showed a rhodamine peak corresponding
to a tetramer (A585nm) and a non-£uorescent peak
(A214nm) corresponding to a dimer (data not shown)
suggesting the formation of two di¡erent homo-
oligomers, a RhPP-5 tetramer and a PP-5HB dimer.
3.4. PP-5 promotes vesicle aggregation
To determine whether the stoichiometry necessary
for depolarization was also that necessary to pro-
mote vesicle aggregation (i.e. suggesting similar
mechanistic steps), we investigated the concentration
dependence of PP-5 promoted vesicle aggregation
[34]. As the ratio of PP-5 to lipid was increased, a
non-linear relationship between concentration and
extent of aggregation was observed (Fig. 6). Vesicle
aggregation was markedly sensitive to PP-5, with ag-
gregatory e¡ects seen at a molar ratio of peptide to
phospholipid equal to 2.0U1033. The relative
amount of PP-5 required to promote aggregation is
less than that previously shown to be necessary to
promote model membrane fusion [34] or PP-5 depen-
dent depolarization. In contrast to PP-5 mediated
depolarization (Fig. 2), which is inhibited by PP-
5AB, neither PP-5AB nor PP-5HB, in an equimolar
concentration with PP-5, a¡ected PP-5 induced
vesicle aggregation (data not shown). Neither PP-
5AB nor PP-5HB alone promoted vesicle aggrega-
tion at any concentration studied (data not shown),
indicating that an amphiphilic K-helix as seen in WT
PP-5 is necessary for aggregation. These results show
that PP-5 induced vesicle aggregation occurs at much
lower molar ratio of peptide to phospholipid than
PP-5 dependent depolarization (molar ratio of
2.0U1033 versus molar ratio of 0.4, respectively).
Moreover, only PP-5 induced membrane depolariza-
tion is susceptible to inhibition by PP-5AB.
Fig. 6. PP-5 induced calcium dependent vesicle aggregation.
The maximum change in absorbance at 380 nm of
PC:PS:CHOL (4:4:1) vesicles in the presence of increasing con-
centrations of PP-5 (b) or equimolar mixtures of PP-5 and PP-
5AB (a) is shown at 37‡C. The calcium concentration in these
assays was 16 WM as described in Section 2. The results are a
summary of two independent experiments with two di¡erent
batches of PP-5.
Fig. 5. Elution pro¢le of equimolar mixtures of RhPP-5 and
PP-5AB. The elution pro¢le of an equimolar mixture of RhPP-
5 with PP-5AB separated on a HR10/30 Superdex column
eluted with an isocratic gradient of 0.25 M NaCl in 0.02 M
Na2HPO4 pH 7.40 at a £ow rate of 0.50 ml/min was monitored
at 585 nm and 214 nm. Peak C corresponds to a species with a
molecular weight consistent with a rhodamine moiety in solu-
tion.
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3.5. Predicted e¡ects of PP-5 oligomers on membrane
aggregation and depolarization
The data in Figs. 2 and 6 show a qualitatively
albeit not quantitatively similar non-linear relation-
ship between membrane depolarization (Fig. 2) or
vesicle aggregation (Fig. 6) and peptide/phospholipid
ratio. Since oligomeric complexes of PP-5 were
present under non-denaturing conditions we wished
to learn whether these higher order oligomeric com-
plexes of PP-5 accounted for the apparent dose re-
sponse seen in the aggregation and depolarization
data. Therefore, the data in Figs. 1 and 6 were ana-
lyzed using a modi¢ed Hill analysis (Fig. 7A,B). The
slope of the plot of log[PP-5] versus log[Y/13Y] for
membrane depolarization (i.e. the Hill coe⁄cient)
was equal to 3.725 (Fig. 7A), suggesting that PP-5
may form a tetrameric or higher order oligomer to
promote depolarization. In contrast to membrane
depolarization, when the PP-5 induced vesicle aggre-
gation data (Fig. 1) were similarly analyzed (Fig.
7B), the slope of the plot was calculated to be
1.324, suggesting that PP-5 self-assembly may not
be required for aggregation.
4. Discussion
We have previously provided evidence supporting
the hypothesis that peripherin/rds is a photoreceptor
speci¢c membrane fusion protein [33,34]. A fusion
peptide region of this protein has been identi¢ed
within the C-terminus, corresponding to amino acid
residues 311^325. This region is modeled by a syn-
thetic peptide, termed PP-5, which has previously
been shown to promote membrane aggregation and
fusion, as measured by aqueous contents mixing [34].
The present study extends our characterization of
PP-5 by showing that PP-5 promotes membrane de-
polarization, and by inference membrane destabiliza-
tion. In addition, other synthetic peptides corre-
sponding to overlapping regions within the C-
terminus of peripherin/rds (from amino acid residues
308 to 345) did not promote membrane aggregation
[34], aqueous contents mixing [34] or depolarization
(results presented herein). These observations pro-
vide additional support for a speci¢city of a fusion
peptide region within amino acids 311^324.
The salient observation in this study is that mem-
brane depolarization and by inference membrane de-
stabilization require an oligomer of PP-5. A tetra-
meric complex of PP-5 was detected in both size
exclusion chromatography experiments (Fig. 4A
and B, Table 2) and non-denaturing tricine gel elec-
trophoresis (Table 2). In addition, self-assembly of
PP-5 into multimeric complex was demonstrated us-
ing RhPP-5, in the presence of vesicles of identical
size and composition as in the depolarization studies.
Cooperativity was reinforced with a Hill analysis of
Fig. 7. Modi¢ed Hill analysis of aggregation and depolarization
data. (A) Hill plot of log[Y/Ymax3Y] versus log[PP-5] was con-
structed from the data shown in Fig. 2 and similar experiments
(n = 21 data points). Y was de¢ned as the percent £uorescence
recovery and Ymax the maximal percent recovery determined
with the addition of mellitin. The slope of the plot of log[pep-
tide concentration] versus log Y/[Ymax3Y] is equal to the Hill
coe⁄cient and was calculated using Sigma-plot linear regression
software. The data were ¢rst analyzed using Sigma Stat to de-
termine whether the best ¢t was a ¢rst or second order equa-
tion. (B) Hill plot of log[Y/Ymax3Y] versus log[PP-5] was con-
structed from the data shown in Fig. 6 and similar experiments
(n = 9 data points). Y was de¢ned as the absorbance at 380 nm
and Ymax the maximum absorbance at 380 nm. The slope of
the plot of log[peptide concentration] versus log Y/[Ymax3Y] is
equal to the Hill coe⁄cient and was calculated using Sigma-
plot linear regression software.
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the depolarization data, which resulted in a calcu-
lated slope of the Hill plot equal to 3.754 (Fig.
7A), suggesting that a tetrameric arrangement of
PP-5 monomers may be required for maximal depo-
larization and by inference destabilization but not
aggregation (Fig. 7B).
The amphiphilic K-helical structure of PP-5 is a
common feature of other fusion peptides [68,69].
To elucidate the relationship between PP-5 structure
and function, two mutant peptides which altered the
amphiphilic nature of the K-helix of PP-5 (PP-5AB)
or the K-helical structure (PP-5HB) were studied. In-
terestingly, PP-5HB had no e¡ect on PP-5 dependent
depolarization, but PP-5AB inhibited PP-5 depen-
dent membrane depolarization. An understanding
of the action of PP-5AB and by inference wild type
PP-5 can be obtained from an analysis of the proper-
ties of PP-5 and PP-5AB and PP-5HB. The mutant
peptide PP-5AB inhibited PP-5 induced membrane
depolarization. The mechanism of PP-5AB inhibitory
action appears to be via the formation of a non-
functional heterotetrameric complex. Experiments
using rhodamine labeled PP-5 (Figs. 4 and 5) and
PP-5AB detected a dimer and a tetramer at both
A214nm (peptide absorbance) and at A585nm (rhod-
amine absorbance). Because the molecular mass of
the larger species (8200 Da) detected at both absor-
bances is exactly that predicted from an arithmetic
sum of the molecular masses of two rhodamine PP-5s
and two PP-5ABs, it can be concluded that a hetero-
tetramer, rather than a homotetramer, is the domi-
nant species present. If a PP-5 AB homotetramer was
present then an additional peak at A214nm would have
been detected with a molecular mass of 3700 Da
(between peaks A and B in Fig. 5), with no corre-
sponding peak observed at A585nm. PP-5AB inhibi-
tion of PP-5 dependent action suggests that the
PP-5-PP-5AB heterotetramer does not induce depo-
larization (Fig. 3). Since PP-5 and PP-5AB form a
heterotetramer it can be inferred that amphiphilicity
is not required for complex formation. In studies of
peptides of HA2, the elimination of the amphiphilic
characteristic abolished fusion due to a disruption of
the K-helical structure [69]. In contrast, when the
amphiphilic nature of the K-helix in the WAE model
peptide was altered an increase in fusion activity was
observed [70]. However, in neither one of those stud-
ies was the oligomeric state of the peptides investi-
gated. More recently, work with a net negative am-
phiphilic peptide has shown that this peptide must be
anchored to liposomes to promote fusion [71]. Such
studies remain to be carried out with PP-5.
In contrast to PP-5AB, PP-5HB formed a disor-
dered secondary structure which had no e¡ect on PP-
5 dependent membrane depolarization or vesicle ag-
gregation (Fig. 2 and data not shown). Equimolar
mixtures of PP-5 and PP-5HB formed dimers and
tetramers with an unknown molecular stoichiometry
within these complexes. Since PP-5 HB does not in-
hibit membrane depolarization, it can be inferred
that PP-5HB forms homodimers and PP-5 forms ho-
motetramers in these mixtures. Thus, PP-5HB does
not prevent the self-assembly of PP-5 to a homo-
tetramer. This interpretation is con¢rmed by Hill
analysis of depolarization data using PP-5-PP-5HB,
in which the Hill coe⁄cient was approx. 4 indicating
that the depolarization competent species was most
likely a PP-5 homotetramer.
The hypothesis that the fusion peptide of periph-
erin/rds modeled by PP-5 forms oligomers which are
necessary for membrane depolarization is consistent
with other fusion peptides [2^4], lending additional
support for the role of this region of the native pro-
tein in promoting membrane fusion. This hypothesis
is also consistent with our previously published work
reporting an inhibition of fusion between R18 labeled
ROS plasma membrane and peripherin/rds recombi-
nants by PP-5. In those experiments it is proposed
that the inhibition of fusion results from the interac-
tion of PP-5 with its corresponding region in native
peripherin/rds. Such an interaction may result in im-
proper self-assembly of the native protein. The for-
mation of a higher order oligomeric complex by na-
tive peripherin/rds was also documented using
sedimentation analysis [44]. The precise stoichiome-
try of the fusion competent form of native peripher-
in/rds remains to be determined. The demonstration
that PP-5 promotes membrane depolarization and
membrane aggregation provides additional and
more compelling support for its role in ROS mem-
brane fusion processes and the identi¢cation of this
region of native peripherin/rds as a fusion peptide
domain.
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